← The Wire
XENENasdaq
Xenon Pharmaceuticals Inc.
Pharmaceutical Preparations · A1 · CIK 1582313
Xenon Pharmaceuticals discovers, develops, and commercializes neuroscience therapeutics for patients in need
red 8-K · 90d
$5.04B
Market cap
$60.13
Last close
+0.7%
1D
+9.8%
5D
1.7M
Volume
Price · last 39 sessions+4.8%
May 4L $51.21 · H $60.13Jun 29
250
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 3, 202610-Q10-QMay 7, 20268-KResults of Operations · Reg FD DisclosureMay 7, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KExecutive ChangeApr 13, 20268-KCompany UpdateMar 13, 20268-KMaterial Agreement · Company UpdateMar 12, 2026424B5424B5Mar 12, 2026424B5424B5Mar 9, 20268-KReg FD DisclosureMar 9, 20268-KCompany UpdateFeb 27, 2026424B5424B5Feb 27, 202610-K10-KFeb 26, 20268-KResults of Operations · Reg FD DisclosureFeb 26, 20268-KExecutive ChangeDec 1, 202510-Q10-QNov 3, 20258-KResults of Operations · Reg FD DisclosureNov 3, 20258-K/AExecutive Change · Company UpdateOct 17, 20258-KExecutive ChangeOct 16, 202510-Q10-QAug 11, 20258-KResults of Operations · Reg FD DisclosureAug 11, 20258-KExecutive ChangeJul 3, 20258-KShareholder VoteJun 5, 202510-Q10-QMay 12, 20258-KResults of Operations · Reg FD DisclosureMay 12, 2025DEFA14ADEFA14AApr 24, 2025DEF 14ADEF 14AApr 24, 20258-KCompany UpdateMar 17, 20258-KAuditor ChangeMar 5, 202510-K10-KFeb 27, 20258-KExecutive Change · Results of OperationsFeb 27, 20258-KExecutive ChangeJan 17, 202510-Q10-QNov 12, 20248-KResults of Operations · Reg FD DisclosureNov 12, 202410-Q10-QAug 8, 20248-KResults of Operations · Reg FD DisclosureAug 8, 20248-KShareholder VoteJun 5, 202410-Q10-QMay 9, 20248-KResults of Operations · Reg FD DisclosureMay 9, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive ChangeApr 19, 20248-KCompany UpdateMar 8, 202410-K10-KFeb 29, 20248-KResults of Operations · Reg FD DisclosureFeb 29, 2024SC 13GSEC SCHEDULE 13GFeb 8, 2024424B5424B5Nov 30, 20238-KMaterial Agreement · Company UpdateNov 30, 2023424B5424B5Nov 29, 20238-KCompany UpdateNov 27, 20238-KCompany UpdateNov 9, 202310-Q10-QNov 8, 20238-KResults of Operations · Reg FD DisclosureNov 8, 202310-Q10-QAug 9, 20238-KAcquisition / Disposition · Reg FD DisclosureAug 9, 20238-KExecutive ChangeAug 8, 20238-KShareholder VoteJun 2, 202310-Q10-QMay 9, 20238-KResults of Operations · Reg FD DisclosureMay 9, 2023DEF 14ADEF 14AApr 27, 20238-KExecutive ChangeMar 14, 20238-KCompany UpdateMar 8, 202310-K10-KMar 1, 20238-KResults of Operations · Reg FD DisclosureMar 1, 202310-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KCompany UpdateNov 7, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 2022424B5424B5Jun 23, 20228-KCompany UpdateJun 23, 2022424B5424B5Jun 22, 20228-KCompany UpdateJun 21, 20228-KExecutive Change · Shareholder VoteJun 2, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEF 14ADEF 14AApr 28, 20228-KEquity IssuanceMar 22, 20228-KResults of Operations · Company UpdateMar 10, 2022424B5424B5Mar 1, 2022
Insider Activity
In the 90 days to Mar 13, 2026: 3 sold $19.6M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 7,308 | $55.23 | $404K |
| Mar 13, 2026 | Kenney Christopher JohnChief Medical Officer | Sell | 1,410 | $55.23 | $78K |
| Mar 13, 2026 | Difabio AndreaChief Legal Officer | Sell | 1,342 | $55.23 | $74K |
| Mar 10, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 11,269 | $60.11 | $677K |
| Mar 10, 2026 | Kenney Christopher JohnChief Medical Officer | Sell | 2,771 | $60.11 | $167K |
| Mar 10, 2026 | Difabio AndreaChief Legal Officer | Sell | 2,607 | $60.11 | $157K |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 65,000 | $62.06 | $4.0M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 61,652 | $60.08 | $3.7M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 43,348 | $59.26 | $2.6M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 31,694 | $59.88 | $1.9M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 21,515 | $60.49 | $1.3M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 21,791 | $58.81 | $1.3M |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 12,479 | $59.50 | $743K |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 10,072 | $60.47 | $609K |
| Mar 9, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 2,449 | $61.26 | $150K |
| Jan 2, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 37,938 | $44.40 | $1.7M |
| Jan 2, 2026 | Mortimer IanPRESIDENT & CEO | Sell | 2,062 | $44.93 | $93K |
| Dec 8, 2025 | Mortimer IanPRESIDENT & CEO | Sell | 8,820 | $45.59 | $402K |
| Dec 8, 2025 | Mortimer IanPRESIDENT & CEO | Sell | 2,010 | $46.32 | $93K |
| Dec 5, 2025 | Mortimer IanPRESIDENT & CEO | Sell | 14,375 | $45.03 | $647K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance